{"SPADE_UN_28230": {"Sequence Information": {"Peptide Name": "Tritrpticin [R2,3,12,13K] -AMD", "Sequence": "VKKFPWWWPFLKK", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "2I1E", "UniProt Entry": [{"uniprotId": "P51524", "uniprotUrl": "http://www.uniprot.org/uniprot/P51524", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "P51525", "uniprotUrl": "http://www.uniprot.org/uniprot/P51525", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures.", "Pubmed ID": "24086578", "Reference": "Biophys J. 2006;91:4413-4426", "Author": "Schibli DJ, Nguyen LT, Kernaghan SD, Rekdal Ø, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24086578"}, {"Title": "Investigating the cationic side chains of the antimicrobial peptide tritrpticin: hydrogen bonding properties govern its membrane-disruptive activities.", "Pubmed ID": "21641334", "Reference": "Biochim Biophys Acta. 2011;1808:2297-2303", "Author": "Nguyen LT, de Boer L, Zaat SA, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21641334"}, {"Title": "Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.", "Pubmed ID": "29671805", "Reference": "Biomolecules. 2018;8:E19", "Author": "Arias M, Piga KB, Hyndman ME, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29671805"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "Mass": 1790.2, "PI": 10.48, "Net Charge": 4, "Hydrophobicity": -0.61, "Frequent Amino Acids": "KWF", "Absent Amino Acids": "ACDEGHIMNOQRSTUY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 9, "Positive Residues": 4, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28230", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_05479", "Similarity": 1.0, "Sequence": "TVVKKRVKK"}, {"SPADE_ID": "SPADE_UN_05909", "Similarity": 1.0, "Sequence": "IFWRRIVIVKKF"}, {"SPADE_ID": "SPADE_UN_28230", "Similarity": 1.0, "Sequence": "VKKFPWWWPFLKK"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=>1000 µg/ml,Human erythrocytes:5% Hemolysis=120 µM,Human PBMC:IC50=41.0 µM", "Target Organism": "Escherichia coli(MIC=20µg/ml),Staphylococcus aureus(MIC=10µg/ml),Escherichia coli(MBC=20µg/ml),Staphylococcus aureus(MBC=10µg/ml),Bacillus subtilis ATCC 6633(LC=<0.45µM),Staphylococcus aureus 42D(LC=1.9µM),Escherichia coli ML-35(LC=0.45µM),Escherichia coli ATCC 25922(MIC=16µM),Jurkat T-cell leukemia(IC50=11.5µM)"}}}